Cavitation Technologies, Inc.
CVAT · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.87 | 0.00 | 0.07 | -0.01 |
| FCF Yield | -1.96% | -2.60% | -2.89% | -3.74% |
| EV / EBITDA | -44.76 | -6.19 | -36.39 | 8.31 |
| Quality | ||||
| ROIC | 638.46% | -114.71% | -52.41% | -249.17% |
| Gross Margin | 0.00% | 100.00% | 79.51% | 82.89% |
| Cash Conversion Ratio | 0.85 | 0.77 | 1.08 | -0.35 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.40% | -22.26% | -14.14% | -1.88% |
| Free Cash Flow Growth | -20.33% | 26.61% | -23.38% | -14.86% |
| Safety | ||||
| Net Debt / EBITDA | 0.12 | 0.10 | 1.30 | -0.93 |
| Interest Coverage | 27.67 | -234.00 | -114.00 | -149.50 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 1.18 |
| Cash Conversion Cycle | 150.00 | 180.00 | -417.60 | -1,059.23 |